Skip to main content
Top
Published in: Journal of Neurology 8/2019

01-08-2019 | Subarachnoid Hemorrhage | Original Communication

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review

Authors: Mizuho Sugiyama, Yuji Ueno, Hikaru Kamo, Yoko Edahiro, Nobukazu Miyamoto, Kazuo Yamashiro, Ryota Tanaka, Yasushi Shimo, Norio Komatsu, Nobutaka Hattori

Published in: Journal of Neurology | Issue 8/2019

Login to get access

Abstract

Background

JAK2 V617F mutation increases the risk of thrombosis, and both ischemic and hemorrhagic strokes can occur in essential thrombocythemia (ET). The mechanisms underlying ischemic stroke in ET are diverse, and hemorrhagic stroke has rarely been reported in ET.

Methods

Among 627 stroke patients, those identified as having ET were investigated retrospectively. A comprehensive systemic literature search of the PubMed database was also conducted.

Results

Two cases were extracted with the diagnosis of ET who developed SAH and then ischemic stroke. In Case 1, a 47-year-old woman developed SAH in the left high convexity. Eleven hours later, acute cerebellar infarction suddenly developed due to right vertebral artery dissection. In Case 2, a 70-year-old woman developed SAH in the right high convexity. Magnetic resonance angiography showed multifocal stenotic changes in intracranial arteries. Three days later, she developed acute brain infarcts in the right middle cerebral artery territory. Eight weeks later, multifocal stenotic lesions improved. The literature review revealed 5 patients with hemorrhagic stroke and 40 patients with ischemic stroke associated with ET. Age at onset varied, female gender predominated, and the frequency of JAK2 V617F mutation was high. Atherosclerotic vascular risk factors were more common in ischemic stroke, but not in hemorrhagic stroke.

Conclusions

The current study describes rare cases of SAH accompanied by ischemic stroke secondary to ET along with a review of the current literature, implying specific mechanisms for cerebral artery disorders associated with JAK2 V617F mutation.
Literature
1.
go back to reference Tefferi A (2013) Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88:507–516CrossRefPubMed Tefferi A (2013) Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88:507–516CrossRefPubMed
2.
go back to reference Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779–1790CrossRefPubMed Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779–1790CrossRefPubMed
3.
go back to reference Fabris F, Randi ML (2009) Essential thrombocythemia: past and present. Intern Emerg Med 4:381–388CrossRefPubMed Fabris F, Randi ML (2009) Essential thrombocythemia: past and present. Intern Emerg Med 4:381–388CrossRefPubMed
4.
go back to reference Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Buller HR, Cattaneo M (2009) Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res 124:409–417CrossRefPubMed Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Buller HR, Cattaneo M (2009) Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res 124:409–417CrossRefPubMed
5.
go back to reference Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Finazzi G, Gangat N, Tefferi A, Barbui T (2011) Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117:5857–5859CrossRefPubMed Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Finazzi G, Gangat N, Tefferi A, Barbui T (2011) Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117:5857–5859CrossRefPubMed
6.
go back to reference Richard S, Perrin J, Baillot PA, Lacour JC, Ducrocq X (2011) Ischaemic stroke and essential thrombocythemia: a series of 14 cases. Eur J Neurol 18:995–998CrossRefPubMed Richard S, Perrin J, Baillot PA, Lacour JC, Ducrocq X (2011) Ischaemic stroke and essential thrombocythemia: a series of 14 cases. Eur J Neurol 18:995–998CrossRefPubMed
7.
go back to reference Kato Y, Hayashi T, Sehara Y, Deguchi I, Fukuoka T, Maruyama H, Horiuchi Y, Nagamine Y, Sano H, Tanahashi N (2015) Ischemic stroke with essential thrombocythemia: a case series. J Stroke Cerebrovasc Dis 24:890–893CrossRefPubMed Kato Y, Hayashi T, Sehara Y, Deguchi I, Fukuoka T, Maruyama H, Horiuchi Y, Nagamine Y, Sano H, Tanahashi N (2015) Ischemic stroke with essential thrombocythemia: a case series. J Stroke Cerebrovasc Dis 24:890–893CrossRefPubMed
8.
go back to reference Adam R, Priglinger M, Harrington T, Gottlieb D, Krause M (2014) An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia. J Stroke Cerebrovasc Dis 23:e373–e374CrossRefPubMed Adam R, Priglinger M, Harrington T, Gottlieb D, Krause M (2014) An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia. J Stroke Cerebrovasc Dis 23:e373–e374CrossRefPubMed
9.
go back to reference Freilinger T, Saam T, Duering M, Dichgans M, Peters N (2011) Internal carotid artery dissection and ischemic cerebral infarction in the setting of essential thrombocythemia. Clin Appl Thromb Hemost 17:E138–E140CrossRefPubMed Freilinger T, Saam T, Duering M, Dichgans M, Peters N (2011) Internal carotid artery dissection and ischemic cerebral infarction in the setting of essential thrombocythemia. Clin Appl Thromb Hemost 17:E138–E140CrossRefPubMed
10.
go back to reference D’Ambrosio D, Della-Morte D, Gargiulo G, Rossetti M, Rundek T, Rengo F, Abete P (2008) Intrapetrous internal carotid artery dissection and essential thrombocythemia: what relationship? A case report. Cases J 1:354PubMed D’Ambrosio D, Della-Morte D, Gargiulo G, Rossetti M, Rundek T, Rengo F, Abete P (2008) Intrapetrous internal carotid artery dissection and essential thrombocythemia: what relationship? A case report. Cases J 1:354PubMed
11.
go back to reference Miller TD, Farquharson MH (2010) Essential thrombocythaemia and its neurological complications. Pract Neurol 10:195–201CrossRefPubMed Miller TD, Farquharson MH (2010) Essential thrombocythaemia and its neurological complications. Pract Neurol 10:195–201CrossRefPubMed
12.
go back to reference Bogousslavsky J, Van Melle G, Regli F (1988) The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19:1083–1092CrossRef Bogousslavsky J, Van Melle G, Regli F (1988) The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19:1083–1092CrossRef
13.
go back to reference Choi KD, Jo JW, Park KP, Kim JS, Lee TH, Kim HJ, Jung DS (2007) Diffusion-weighted imaging of intramural hematoma in vertebral artery dissection. J Neurol Sci 253:81–84CrossRefPubMed Choi KD, Jo JW, Park KP, Kim JS, Lee TH, Kim HJ, Jung DS (2007) Diffusion-weighted imaging of intramural hematoma in vertebral artery dissection. J Neurol Sci 253:81–84CrossRefPubMed
14.
go back to reference Kato A, Shinohara Y, Yamashita E, Fujii S, Miyoshi F, Kuya K, Ogawa T (2015) Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection. Neuroradiology 57:909–915CrossRefPubMed Kato A, Shinohara Y, Yamashita E, Fujii S, Miyoshi F, Kuya K, Ogawa T (2015) Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection. Neuroradiology 57:909–915CrossRefPubMed
15.
16.
go back to reference Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101CrossRefPubMed Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101CrossRefPubMed
17.
go back to reference Arboix A, Besses C, Acin P, Massons JB, Florensa L, Oliveres M, Sans-Sabrafen J (1995) Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke 26:1463–1466PubMed Arboix A, Besses C, Acin P, Massons JB, Florensa L, Oliveres M, Sans-Sabrafen J (1995) Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke 26:1463–1466PubMed
18.
go back to reference Verdure P, Lefaucheur R, Guegan-Massardier E, Triquenot-Bagan A, Gerardin E, Maltete D (2012) Bilateral vertebral artery dissection and essential thrombocythemia with JAK2 mutation. Rev Neurol (Paris) 168:543–544CrossRef Verdure P, Lefaucheur R, Guegan-Massardier E, Triquenot-Bagan A, Gerardin E, Maltete D (2012) Bilateral vertebral artery dissection and essential thrombocythemia with JAK2 mutation. Rev Neurol (Paris) 168:543–544CrossRef
19.
go back to reference Posfai E, Marton I, Szoke A, Borbenyi Z, Vecsei L, Csomor A, Sas K (2014) Stroke in essential thrombocythemia. J Neurol Sci 336:260–262CrossRefPubMed Posfai E, Marton I, Szoke A, Borbenyi Z, Vecsei L, Csomor A, Sas K (2014) Stroke in essential thrombocythemia. J Neurol Sci 336:260–262CrossRefPubMed
20.
go back to reference Trifan G, Shafi N, Testai FD (2018) Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis 27:2572–2578CrossRefPubMed Trifan G, Shafi N, Testai FD (2018) Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis 27:2572–2578CrossRefPubMed
21.
go back to reference Charles M, Fontoura R, Sugalski G (2016) Early recognition of intraventricular hemorrhage in the setting of thrombocytosis in the emergency department. Open Access Emerg Med 8:29–33CrossRefPubMedPubMedCentral Charles M, Fontoura R, Sugalski G (2016) Early recognition of intraventricular hemorrhage in the setting of thrombocytosis in the emergency department. Open Access Emerg Med 8:29–33CrossRefPubMedPubMedCentral
23.
go back to reference Kondlapudi J, O’Connor RJ, Mawer S (2009) Cerebral haemorrhage as the presenting feature of myeloproliferative disorder. BMJ Case Rep 2009 Kondlapudi J, O’Connor RJ, Mawer S (2009) Cerebral haemorrhage as the presenting feature of myeloproliferative disorder. BMJ Case Rep 2009
24.
go back to reference Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH (2006) The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 32:589–604CrossRefPubMed Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH (2006) The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 32:589–604CrossRefPubMed
25.
go back to reference Schievink WI (2001) Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 344:898–906CrossRef Schievink WI (2001) Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 344:898–906CrossRef
26.
go back to reference Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Colomer D, Cervantes F (2006) Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. Haematologica 91:169–175PubMed Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Colomer D, Cervantes F (2006) Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. Haematologica 91:169–175PubMed
27.
go back to reference Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M, Manarini S, Finazzi G, Cerletti C, Barbui T (2000) Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96:4261–4266PubMed Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M, Manarini S, Finazzi G, Cerletti C, Barbui T (2000) Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96:4261–4266PubMed
28.
go back to reference Etheridge SL, Roh ME, Cosgrove ME, Sangkhae V, Fox NE, Chen J, Lopez JA, Kaushansky K, Hitchcock IS (2014) JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms. Proc Natl Acad Sci U S A 111:2295–2300CrossRefPubMedPubMedCentral Etheridge SL, Roh ME, Cosgrove ME, Sangkhae V, Fox NE, Chen J, Lopez JA, Kaushansky K, Hitchcock IS (2014) JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms. Proc Natl Acad Sci U S A 111:2295–2300CrossRefPubMedPubMedCentral
29.
go back to reference Solberg LA Jr, Tefferi A, Oles KJ, Tarach JS, Petitt RM, Forstrom LA, Silverstein MN (1997) The effects of anagrelide on human megakaryocytopoiesis. Br J Haematol 99:174–180CrossRefPubMed Solberg LA Jr, Tefferi A, Oles KJ, Tarach JS, Petitt RM, Forstrom LA, Silverstein MN (1997) The effects of anagrelide on human megakaryocytopoiesis. Br J Haematol 99:174–180CrossRefPubMed
30.
go back to reference Gisslinger H, Gotic M, Holowiecki J, Penka M, Thiele J, Kvasnicka HM, Kralovics R, Petrides PE, Group AS (2013) Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood 121:1720–1728CrossRefPubMedPubMedCentral Gisslinger H, Gotic M, Holowiecki J, Penka M, Thiele J, Kvasnicka HM, Kralovics R, Petrides PE, Group AS (2013) Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood 121:1720–1728CrossRefPubMedPubMedCentral
31.
go back to reference Storen EC, Tefferi A (2001) Long-term use of anagrelide in young patients with essential thrombocythemia. Blood 97:863–866CrossRefPubMed Storen EC, Tefferi A (2001) Long-term use of anagrelide in young patients with essential thrombocythemia. Blood 97:863–866CrossRefPubMed
32.
go back to reference Alvarez-Larran A, Cervantes F, Pereira A, Arellano-Rodrigo E, Perez-Andreu V, Hernandez-Boluda JC, Ayats R, Salvador C, Muntanola A, Bellosillo B, Vicente V, Hernandez-Nieto L, Burgaleta C, Xicoy B, Besses C (2010) Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood 116:1205–1210 (quiz 1387) CrossRefPubMed Alvarez-Larran A, Cervantes F, Pereira A, Arellano-Rodrigo E, Perez-Andreu V, Hernandez-Boluda JC, Ayats R, Salvador C, Muntanola A, Bellosillo B, Vicente V, Hernandez-Nieto L, Burgaleta C, Xicoy B, Besses C (2010) Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood 116:1205–1210 (quiz 1387) CrossRefPubMed
Metadata
Title
Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review
Authors
Mizuho Sugiyama
Yuji Ueno
Hikaru Kamo
Yoko Edahiro
Nobukazu Miyamoto
Kazuo Yamashiro
Ryota Tanaka
Yasushi Shimo
Norio Komatsu
Nobutaka Hattori
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09347-4

Other articles of this Issue 8/2019

Journal of Neurology 8/2019 Go to the issue